High platelet counts increase metastatic risk in huge hepatocellular carcinoma undergoing transarterial chemoembolization
Authors:
- 10 March 2016
- journal article
- Published by Wiley in Hepatology Research
- Vol. 46 (10) , 1028-1036
Abstract
Aim: Accumulating evidence suggests platelets play critical roles in tumor metastasis. Moreover, the role of platelets in metastasis is partially correlated with inflammation. However, evidence regarding the contribution of platelets to hepatocellular carcinoma (HCC) metastasis is lacking. This study investigated the association between platelets and metastatic risk in HCC.Methods: We used huge HCC (diameter over 10 cm), a tumor subgroup with a strong inflammatory background, as a model to evaluate the potential predictive role of platelets and platelet‐related biomarkers for metastasis in HCC patients undergoing transarterial chemoembolization. A logistic regression model was used to analyze risk factors for metastasis.Results: Patients with huge HCC (n = 178) were enrolled, and 24.7% (44/178) of patients had remote metastases after treatment. Univariate analyses showed high platelet counts (P = 0.012), pretreatment platelet‐to‐lymphocyte ratios (pre‐PLR) of 100 or more (P = 0.018) and post‐PLR of 100 or more (P = 0.013) were potential risk factors for metastasis. Furthermore, multivariate analyses showed high platelet counts (odds ratio, 2.18; 95% confidence interval, 1.074–4.443; P = 0.031) and platelet‐related biomarkers were independent risk factors for HCC metastasis. Particularly, the risk of metastasis in patients with high post‐PLR values was significantly greater than patients with low post‐PLR values. For tumor response and survival, patients with high platelet counts had faster disease progression (P = 0.002) and worse survival (P < 0.0001).Conclusion: High platelet counts increase the extrahepatic metastasis risk of huge HCC undergoing chemoembolization, which supply clinical verification of the association between high platelet counts and HCC metastasis.Keywords
Funding Information
- Natural Science Foundation of Shanghai Municipality (no. 15ZR1407100)
This publication has 31 references indexed in Scilit:
- Critical Roles of p53 in Epithelial-Mesenchymal Transition and Metastasis of Hepatocellular Carcinoma CellsPLOS ONE, 2013
- Antiangiogenic therapy promoted metastasis of hepatocellular carcinoma by suppressing host-derived interleukin-12b in mouse modelsAngiogenesis, 2013
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular CarcinomaGastroenterology, 2013
- Suppression of Natural Killer Cells by Sorafenib Contributes to Prometastatic Effects in Hepatocellular CarcinomaPLOS ONE, 2013
- Impact of hepatectomy for huge solitary hepatocellular carcinomaJournal of Surgical Oncology, 2012
- Antiplatelet therapy prevents hepatocellular carcinoma and improves survival in a mouse model of chronic hepatitis BProceedings of the National Academy of Sciences, 2012
- Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trialsThe Lancet, 2012
- Paraneoplastic Thrombocytosis in Ovarian CancerNew England Journal of Medicine, 2012
- Direct Signaling between Platelets and Cancer Cells Induces an Epithelial-Mesenchymal-Like Transition and Promotes MetastasisCancer Cell, 2011
- A decade?s studies on metastasis of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2003